Nisa Investment Advisors, LLC Keros Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $19.6 Billion
- Q1 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 3,362 shares of KROS stock, worth $48,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,362
Previous 170
1877.65%
Holding current value
$48,244
Previous $2,000
1600.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding KROS
# of Institutions
178Shares Held
36.4MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$56.6 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$37.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$36.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.1 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$28.7 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $370M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...